Advances in longevity research offer numerous approaches to improving personal health. Through informed decision making, you can benefit from new therapies and technologies that can prevent or slow down age-related diseases. We provide easy-to-understand information on topics such as anti-aging therapies, nutrition and exercise based on the latest scientific findings to help you make the right choices for a longer, healthier life.

Longevity research brings with it important ethical challenges, such as access to life-prolonging therapies and the question of how technologies such as genome editing should be used. There is also the question of how society should respond to the possibility of significantly extending life. Who will benefit from these advances and how can we ensure that they are distributed fairly? We will discuss these and other questions openly and transparently.

The most important technologies include genome editing (e.g. CRISPR/Cas9), neurotechnology, stem cell therapies and artificial intelligence (AI). These technologies make it possible to understand and influence ageing at a genetic, cellular and neurological level. They help to combat age-related diseases and prolong life by maintaining the health of cells, organs and the brain.

Research into longevity has the potential not only to extend lifespan, but also to improve quality of life. This affects you in many ways, from preventative medical measures to targeted therapies for age-related diseases. By having access to new technologies such as senolytic drugs or stem cell therapies, we can age healthier, work longer and actively shape our lives. This means that you can make decisions today that will influence your future in old age, from lifestyle changes to the use of science-based therapies.

Progress in longevity research is taking place in different phases. Some technologies, such as nutritional science and senolytic drugs, are already being tested and will be commercially available in the coming years. Other breakthroughs, such as genome editing to extend life or neurotechnologies to improve cognitive abilities, are of a long-term nature and could become marketable in the coming decades. The exact time horizon depends on the results of ongoing clinical trials and regulatory decisions. Overall, we could see significant advances in longevity research in the next 10 to 20 years.

Transhumanism is a philosophical movement that aims to push the boundaries of human biology through the use of advanced technologies. This includes not only the extension of life, but also the enhancement of physical and mental capabilities through genetic modification, neurotechnology and artificial intelligence. In the context of longevity research, transhumanism means that humans may be able to overcome physical and cognitive limitations to live longer and more capable lives. This vision goes far beyond simple life extension and encompasses the idea of influencing human evolution through technology.

The most significant breakthroughs in longevity research include:

• Senolytic therapies: These drugs aim to remove ageing cells that accelerate the ageing process. Initial clinical studies have shown that this can regenerate tissue and improve quality of life.
• NAD+ booster: NAD+ is a coenzyme that is important for cell metabolism and DNA repair. Studies have shown that restoring NAD+ levels improves cell function and slows down ageing.
• Genome editing (CRISPR/Cas9): This technology makes it possible to specifically modify genes in order to combat age-related diseases or influence genetic factors of ageing.
• Epigenetic reprogramming: This involves reprogramming cells to return them to a younger state, which offers the possibility of reducing biological age.
• Neurotechnology: Advances in brain-computer interfaces and brain implants have the potential to maintain or improve cognitive abilities in old age.

• The biological lifespan refers to the number of years a person lives, while the healthy lifespan (healthspan) describes the years in which a person lives without significant health restrictions. The goal of longevity research is not only to extend the years of life, but also to ensure that these additional years are spent in good health and quality of life. Technologies and therapies to slow down the ageing process aim to prevent age-related diseases and maintain health into old age.

Genes have a significant influence on the ageing process. Certain genes control cell repair, cell division and resistance to disease, all of which play a role in how quickly a person ages. Research in genetics and epigenetics has shown that certain genetic factors can lead to a longer life, while other genes increase the risk of age-related diseases. Through genome editing, scientists may be able to target these processes to extend lifespan and prevent disease.

Currently, there is no technology that can completely stop the ageing process, but significant advances in research show that ageing could be slowed down and certain aspects even reversed. Studies on epigenetic reprogramming and senolytic therapies have shown that it is possible to restore cells to a younger state and repair age-related damage. However, it remains unclear whether ageing can ever be stopped completely and many of the technologies are still in the early stages of research.

While longevity research is making great strides in the development of new technologies, lifestyle remains a key determinant of lifespan and quality of life. Diet, exercise, stress management and sleep all play an important role in how well the body functions as we age. Calorie restriction and a balanced diet rich in nutrients and antioxidants are scientifically proven ways to promote health and prevent age-related diseases.

Artificial intelligence (AI) and big data have become indispensable tools in longevity research. AI can analyze large amounts of genetic and clinical data to identify patterns that shed light on the aging process and potential interventions. By analyzing this data, AI can help identify biomarkers that indicate a person's biological age and create predictive models to detect age-related diseases early. AI-supported personalized medicine could enable individual health strategies to extend lifespan in the future.

Longevity research not only holds opportunities, but also risks and challenges. A central problem is the ethical question of how the technologies for prolonging life are distributed fairly. There is a risk that only wealthy people will have access to the best therapies, which could reinforce social inequalities. In addition, there are concerns about the safety of new technologies such as genome editing, as long-term consequences are not yet fully known. It is crucial that these technologies are carefully regulated and monitored to avoid misuse.